相关实验视频
Updated: Jul 23, 2025
12:08
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
12.7K
在癌症:朋友或敌人中对性病毒疗法的缺氧影响
Maryam Sadri1, Alireza Najafi1, Ali Rahimi1
1Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
International immunopharmacology
|July 11, 2023
概括
瘤病毒 (OVs) 对癌症治疗有希望,但瘤微环境 (TME) 带来了挑战. 在TME中缺氧影响OV疗效,建议针对性修改以改善癌症病毒治疗结果.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤病毒 (OV) 是一种有前途的癌症治疗策略,特别是在固体瘤中.
- OVs通过直接的瘤细胞溶解和免疫反应诱导产生抗癌作用.
- 免疫抑制性瘤微环境 (TME) 对有效的瘤解毒性病毒疗法构成了重大障碍.
研究的目的:
- 审查癌症病毒疗法的当前进展.
- 讨论TME中缺氧对OV疗效的复杂作用.
- 通过解决缺氧问题,探索优化基于OV的癌症治疗策略.
主要方法:
- 关于型病毒治疗的最新研究的文献综述.
- 对低氧对各种OV类型的双重影响的分析.
- 检查基因和分子修改,以提高低氧性TME的OV性能.
主要成果:
- 在TME中缺氧可以对OV复制产生差异性影响,根据OV加速或抑制它.
- 对OVs或TME修饰的基因操纵以减少缺氧可能会增强抗瘤免疫反应.
- 在低氧性TME中利用具有瘤溶解能力的OV是克服治疗局限性的潜在策略.
结论:
- 了解缺氧的细微影响对于推进型病毒治疗至关重要.
- 针对减轻缺氧的有针对性的策略对于最大限度地发挥OV的治疗潜力至关重要.
- 对OV修饰和TME相互作用的进一步研究将完善癌症治疗方法.
相关概念视频
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:27Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
01:23Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K